This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Sandbox Reserved 1369

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
{{Sandbox_Reserved_HLSC322}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->
{{Sandbox_Reserved_HLSC322}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->
==Your Heading Here (maybe something like 'Structure')==
==Your Heading Here (maybe something like 'Structure')==
-
<StructureSection load='1bna' size='340' side='right' caption='Caption for this structure' scene=''>
+
<StructureSection load='4ZJV' size='340' side='right' caption='Caption for this structure' scene=''>
This is a protein complex formed from Mitogen-Inducible Gene 6 Protein (Mig-6) and Epidermal Growth Factor Receptor (EGFR)4. Mig-6 complexes with and inhibits EGFR. Mig-6 contains a protein domain that can interact with the EGFR protein family4. EGFR catalyzes the phosphorylation of Mig-6 when the two proteins form a complex, and when this occurs, Mig-6 changes its structure and irreversibly inhibits the EGFR4.
This is a protein complex formed from Mitogen-Inducible Gene 6 Protein (Mig-6) and Epidermal Growth Factor Receptor (EGFR)4. Mig-6 complexes with and inhibits EGFR. Mig-6 contains a protein domain that can interact with the EGFR protein family4. EGFR catalyzes the phosphorylation of Mig-6 when the two proteins form a complex, and when this occurs, Mig-6 changes its structure and irreversibly inhibits the EGFR4.
 +
 +
== Function ==
== Function ==
EGFR plays a role in the metastasization and development of carcinomas, because it contributes to growth in epithelial tissue.The irreversible inhibition EGFR by Mig-6 will, in people with cancer, prevent the cancer from growing and progressing further. Therefore, Mig-6 regulates the activities of EGFR, so that growth does not get out of control.
EGFR plays a role in the metastasization and development of carcinomas, because it contributes to growth in epithelial tissue.The irreversible inhibition EGFR by Mig-6 will, in people with cancer, prevent the cancer from growing and progressing further. Therefore, Mig-6 regulates the activities of EGFR, so that growth does not get out of control.
== Disease ==
== Disease ==
-
The Mig-6/EGFR protein complex has great importance to the prevention and suppression of epithelial tumors. Since EGFR promotes epithelial growth, and therefore the growth of epithelial cancers when they occur, the Mig-6/EGFR complex is essentially a tumor suppressing complex, because Mig-6 inhibits the function of EGFR.
+
The Mig-6/EGFR protein complex has great importance to the prevention and suppression of epithelial tumors. Since EGFR promotes epithelial growth, and therefore the growth of epithelial cancers when they occur, the Mig-6/EGFR complex is essentially a tumor suppressing complex, because Mig-6 inhibits the function of EGFR
== Relevance ==
== Relevance ==
-
Mig-6 is a feedback inhibitor that binds, inhibits, and drives internalization of ErbB-family receptors. Mig-6 inactivates the EGFR and thus is critical in better understanding human cancers.
+
Mig-6 is a feedback inhibitor that binds, inhibits, and drives internalization of ErbB-family receptors. Mig-6 inactivates the EGFR and thus is critical in better understanding human cancers2. EGFR phosphorylates Mig6 on Y394 and that this phosphorylation is primed by prior phosphorylation of an adjacent residue, Y395, by Src.
Somatic mutations in the EGFR kinase domain have been shown to drive lung adenocarcinoma, a specific type of lung cancer. Mig-6 is a target for phosphorylation by mutant EGFR’s and is a promising tumor suppressor for mutant-driven lung adenocarcinoma. During a research study, lung tumor formation progressed faster in mice lacking Mig-62. Interaction between Mig-6 and EGFR, stabilizes EGFR, inhibiting mutant EGFR, and preventing or delaying further growth of mutant EGFR-driven tumors.
Somatic mutations in the EGFR kinase domain have been shown to drive lung adenocarcinoma, a specific type of lung cancer. Mig-6 is a target for phosphorylation by mutant EGFR’s and is a promising tumor suppressor for mutant-driven lung adenocarcinoma. During a research study, lung tumor formation progressed faster in mice lacking Mig-62. Interaction between Mig-6 and EGFR, stabilizes EGFR, inhibiting mutant EGFR, and preventing or delaying further growth of mutant EGFR-driven tumors.
Line 20: Line 22:
Global Stoichiometry: Hetero 2-mer - AB2
Global Stoichiometry: Hetero 2-mer - AB2
-
The domain structure of Mig6 includes an N-terminal CRIB domain, a motif that mediates association with the Rho-family GTPase Cdc42 and a C-terminal ErbB-binding region, which is necessary and sufficient for binding and inhibition of EGFR7.
+
The domain structure of Mig6 includes an N-terminal CRIB domain, a motif that mediates association with the Rho-family GTPase Cdc42 and a C-terminal ErbB-binding region, which is necessary and sufficient for binding and inhibition of EGFR7. In the Mig6-YpY structure, the kinase adopts an active conformation, and the Mig6 peptide interacts with the activation loop in an antiparallel manner.
-
This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
+
 
</StructureSection>
</StructureSection>
== References ==
== References ==
-
1. Park, E., Kim, N., Ficarro, S. B., Zhang, Y., Lee, B. I., Cho, A., . . . Eck, M. J. (2015, August 17). Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6. Retrieved February 21, 2018, from https://www.nature.com/articles/nsmb.3074
+
<2. http://www.rcsb.org/structure/4ZJV
-
 
+
3. https://www.ncbi.nlm.nih.gov/pubmed/25735773
-
2. Park, E., Kim, N., Ficarro, S., Zhang, Y., Lee, B., Cho, A., . . . Eck, M. (n.d.). Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6. Retrieved February 21, 2018, from http://www.rcsb.org/structure/4ZJV
+
4. https://www.ncbi.nlm.nih.gov/pubmed/16377102
-
 
+
5. https://www.ebi.ac.uk/pdbe/entry/pdb/4zjv/citations>
-
3. Maity, T. K., Venugopalan, A., Linnoila, I., Cultraro, C. M., Giannakou, A., Nemati, R., . . . Guha, U. (2015, May). Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma. Retrieved February 21, 2018, from https://www.ncbi.nlm.nih.gov/pubmed/25735773
+
-
 
+
-
4. Normanno, N., De, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M. R., . . . Salomon, D. S. (2006, January 17). Epidermal growth factor receptor (EGFR) signaling in cancer. Retrieved February 21, 2018, from https://www.ncbi.nlm.nih.gov/pubmed/16377102
+
-
 
+
-
5. Europe, P. D. (1970, January 01). Structure analysis. Retrieved February 21, 2018, from https://www.ebi.ac.uk/pdbe/entry/pdb/4zjv/citations
+

Revision as of 21:54, 21 February 2018

This Sandbox is Reserved from January through July 31, 2018 for use in the course HLSC322: Principles of Genetics and Genomics taught by Genevieve Houston-Ludlam at the University of Maryland, College Park, USA. This reservation includes Sandbox Reserved 1311 through Sandbox Reserved 1430.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Your Heading Here (maybe something like 'Structure')

Caption for this structure

Drag the structure with the mouse to rotate

References

<2. http://www.rcsb.org/structure/4ZJV 3. https://www.ncbi.nlm.nih.gov/pubmed/25735773 4. https://www.ncbi.nlm.nih.gov/pubmed/16377102 5. https://www.ebi.ac.uk/pdbe/entry/pdb/4zjv/citations>

Personal tools